- Home
- EOI vs ABL Comparison
EOI vs ABL Comparison
Compare EOI & ABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOI
- ABL
- Stock Information
- Founded
- EOI 2004
- ABL 2004
- Country
- EOI United States
- ABL United States
- Employees
- EOI N/A
- ABL N/A
- Industry
- EOI Finance/Investors Services
- ABL Investment Managers
- Sector
- EOI Finance
- ABL Finance
- Exchange
- EOI Nasdaq
- ABL Nasdaq
- Market Cap
- EOI 827.9M
- ABL 741.3M
- IPO Year
- EOI N/A
- ABL N/A
- Fundamental
- Price
- EOI $20.81
- ABL $7.71
- Analyst Decision
- EOI
- ABL Strong Buy
- Analyst Count
- EOI 0
- ABL 4
- Target Price
- EOI N/A
- ABL $13.88
- AVG Volume (30 Days)
- EOI 83.6K
- ABL 200.8K
- Earning Date
- EOI 01-01-0001
- ABL 03-20-2025
- Dividend Yield
- EOI 7.19%
- ABL N/A
- EPS Growth
- EOI N/A
- ABL N/A
- EPS
- EOI N/A
- ABL N/A
- Revenue
- EOI N/A
- ABL $102,407,324.00
- Revenue This Year
- EOI N/A
- ABL $64.51
- Revenue Next Year
- EOI N/A
- ABL $67.47
- P/E Ratio
- EOI N/A
- ABL N/A
- Revenue Growth
- EOI N/A
- ABL 77.68
- 52 Week Low
- EOI $14.36
- ABL $6.75
- 52 Week High
- EOI $18.88
- ABL $12.65
- Technical
- Relative Strength Index (RSI)
- EOI 44.58
- ABL 50.43
- Support Level
- EOI $20.97
- ABL $7.50
- Resistance Level
- EOI $21.16
- ABL $7.93
- Average True Range (ATR)
- EOI 0.25
- ABL 0.32
- MACD
- EOI 0.01
- ABL -0.01
- Stochastic Oscillator
- EOI 40.17
- ABL 50.56
About EOI Eaton Vance Enhance Equity Income Fund Eaton Vance Enhanced Equity Income Fund Shares of Beneficial Interest
Eaton Vance Enhanced Equity Income Fund offers mutual funds that invest across a wide array of equity, income and alternative strategies. The primary investment objective of the fund is to provide current income, with a secondary objective of capital appreciation.
About ABL Abacus Life Inc.
Abacus Life Inc is a vertically integrated alternative asset manager specializing in investing in life insurance products throughout the lifecycle of a life insurance policy.